Aligos Therapeutics

SOUTH SAN FRANCISCO, Calif., July 13, 2026 Aligos Therapeutics announced the completion of patient enrollment in both parts of...

SOUTH SAN FRANCISCO, Calif., July 6, 2026 Aligos Therapeutics has received a $25 million upfront payment from Xiamen Amoytop...

SOUTH SAN FRANCISCO, Calif., April 14, 2026 Aligos Therapeutics, Inc. has announced encouraging progress in its Phase 2 B-SUPREME...